Psoriasis Vulgaris
📧 Sign up to get email alerts when something new happens for Psoriasis Vulgaris.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Efficacy of Topical Metformin in Psoriasis Vulgaris [NA]
A Cairo University-sponsored clinical trial is evaluating the efficacy of topical metformin for psoriasis vulgaris and is currently not recr…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Pre-Post Multimodal Assessment Of Severe Psoriasis Vulgaris Using Clinical, Dermoscopic And QoL Measures
A clinical trial evaluating multimodal assessment (clinical, dermoscopic, and quality-of-life measures) for severe psoriasis vulgaris; statu…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis [Phase 4]
A Phase 4 clinical trial evaluating dose reduction of IL-17 and IL-23 inhibitors in psoriasis has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial) [Phase 2]
Phase 2 trial PLANTCOAT-IIb evaluated a botanical total coumarin cream for psoriasis vulgaris; results on efficacy and safety have been post…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-III) [Phase 3]
Phase 3 clinical trial evaluating the efficacy and safety of a botanical total coumarin cream for treating psoriasis vulgaris; recruitment i…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study [Phase 4]
Phase 4 MEMPSOLAR trial evaluating residual disease memory in psoriasis skin during EnstiLAR therapy and narrow-band UVB treatment; the stud…
-
CLINICAL_TRIALS trial_result · 2025-08-03Clinical Trial Update: Immunogenetic Profiling of Goeckerman Therapy in the Treatment of Psoriasis Vulgaris [Phase 1]
An update on a Phase 1 trial studying immunogenetic profiling of Goeckerman Therapy for psoriasis vulgaris. The study status is terminated.
-
CLINICAL_TRIALS trial_result · 2025-07-03Clinical Trial Update: A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis [Phase 1]
A Phase 1 study evaluating safety, tolerability, and preliminary efficacy of Si-544 in adults with psoriasis vulgaris or psoriatic arthritis…
-
CLINICAL_TRIALS trial_result · 2025-06-15Clinical Trial Update: An Explorative Psoriasis Biomarker Study [NA]
An exploratory biomarker study in psoriasis vulgaris conducted by the Centre for Human Drug Research has been terminated; the document provi…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Special Drug Use-results Survey to Evaluate Safety and Efficacy of Cosentyx in Pediatric Patients With PsV, PsA, or GPP
Special-use survey results assess the safety and efficacy of Cosentyx (secukinumab) in pediatric patients with psoriasis vulgaris, psoriatic…
-
CLINICAL_TRIALS research · 2025-05-04Clinical Trial Update: The Mediterranean Diet and Time-Restricted Eating Dietary Interventions for Psoriasis Study [NA]
A completed clinical trial from King’s College London investigating the Mediterranean diet and time-restricted eating for psoriasis (Psorias…
-
CLINICAL_TRIALS research · 2025-04-01Clinical Trial Update: The Efficacy of Topical Formulation Containing Ciplukan (Physalis Angulata Linn.) on Psoriasis Vulgaris Lesions [Phase 1, Phase 2]
An ongoing Phase 1/Phase 2 clinical trial is evaluating a topical formulation containing Physalis angulata (ciplukan) for psoriasis vulgaris…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Gel in Psoriasis Vulgaris [Phase 2]
A Phase 2 study evaluating the efficacy and safety of calcipotriol plus betamethasone dipropionate gel in psoriasis vulgaris has completed, …
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Long-term Treatment of Scalp Psoriasis With Xamiol® Gel in a Large Adult Chinese Population [Phase 4]
A Phase 4 study assessing long-term treatment of scalp psoriasis with Xamiol Gel in a large adult Chinese population has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Effect of LEO 80185 Gel on the HPA Axis and Calcium Metabolism in Subjects With Extensive Psoriasis Vulgaris [Phase 2]
A Phase 2 trial assessed the effect of LEO 80185 Gel on the HPA axis and calcium metabolism in people with extensive psoriasis vulgaris; the…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Psoriasis Plaque Test on LEO 27989 Ointment and Calcipotriol Plus LEO 27989 Ointment in Patients With Psoriasis Vulgaris [Phase 1]
A Phase 1 trial evaluating LEO 27989 Ointment alone and in combination with calcipotriol in psoriasis vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Psoriasis Plaque Test Comparing Eight Different Formulations of Vitamin D Analogues for the Treatment of Psoriasis [Phase 1]
A Phase 1 clinical trial evaluating eight vitamin D analogue formulations for psoriasis vulgaris has completed. The study explored topical f…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Combined Cumulative Irritation Potential and Repeat Insult Patch Test of LEO 90100 [Phase 1]
Phase 1 study evaluating the skin irritation potential of LEO 90100 using cumulative irritation and repeat insult patch testing. The study i…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Vasoconstriction Study With LEO 90100 [Phase 1]
Phase 1 trial of LEO 90100 for psoriasis vulgaris has completed, reporting results from a vasoconstriction study.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects [Phase 1]
Phase 1 study evaluating skin irritation of LEO 90100 Foam (calcipotriol hydrate plus betamethasone dipropionate) in healthy Japanese volunt…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123) [Phase 2]
Phase 2 clinical trial update for LP0113 spray in psoriasis vulgaris (LP0113-1123); the study status is COMPLETED.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris [Phase 1]
Phase 1 exploratory trial evaluating LEO 29102 in combination with calcipotriol ointment for psoriasis vulgaris; the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Psoriasis Plaque Test Comparing Products for the Treatment of Psoriasis Vulgaris [Phase 1]
Phase 1 clinical trial update from LEO Pharma comparing psoriasis treatments for psoriasis vulgaris has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris [Phase 1]
This clinical trial update reports a Phase 1 exploratory study evaluating different dose combinations of calcipotriol plus betamethasone dip…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: An Exploratory Trial Investigating the Neurogenic Component in Psoriasis Vulgaris by Use of Botulinum Toxin A [Phase 1]
The document reports the completion of a Phase 1 exploratory trial investigating botulinum toxin A for the neurogenic component of psoriasis…